- Home
- EVAX vs SCNX Comparison
EVAX vs SCNX Comparison
Compare EVAX & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- SCNX
- Stock Information
- Founded
- EVAX 2008
- SCNX 2010
- Country
- EVAX Denmark
- SCNX United States
- Employees
- EVAX N/A
- SCNX N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SCNX Other Pharmaceuticals
- Sector
- EVAX Health Care
- SCNX Health Care
- Exchange
- EVAX Nasdaq
- SCNX Nasdaq
- Market Cap
- EVAX 17.8M
- SCNX 21.2M
- IPO Year
- EVAX 2021
- SCNX 2020
- Fundamental
- Price
- EVAX $6.29
- SCNX N/A
- Analyst Decision
- EVAX Strong Buy
- SCNX
- Analyst Count
- EVAX 2
- SCNX 0
- Target Price
- EVAX $11.00
- SCNX N/A
- AVG Volume (30 Days)
- EVAX 4.4M
- SCNX 432.5K
- Earning Date
- EVAX 10-30-2025
- SCNX 11-05-2025
- Dividend Yield
- EVAX N/A
- SCNX N/A
- EPS Growth
- EVAX N/A
- SCNX N/A
- EPS
- EVAX N/A
- SCNX N/A
- Revenue
- EVAX $3,176,000.00
- SCNX $128,202.00
- Revenue This Year
- EVAX N/A
- SCNX N/A
- Revenue Next Year
- EVAX $425.50
- SCNX N/A
- P/E Ratio
- EVAX N/A
- SCNX N/A
- Revenue Growth
- EVAX 1042.45
- SCNX N/A
- 52 Week Low
- EVAX $1.20
- SCNX $0.69
- 52 Week High
- EVAX $15.50
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- EVAX 67.86
- SCNX 31.37
- Support Level
- EVAX $3.70
- SCNX $0.75
- Resistance Level
- EVAX $7.23
- SCNX $0.89
- Average True Range (ATR)
- EVAX 0.66
- SCNX 0.05
- MACD
- EVAX 0.27
- SCNX 0.02
- Stochastic Oscillator
- EVAX 70.78
- SCNX 16.53
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.